Skin Cancer, Thyroid Cancer,
Showing 1 - 25 of >10,000
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media
Recruiting
- Cancer
- +21 more
- Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 7, 2022
Malignant Tumor of Bone and Articular Cartilage, Malignant Tumors of Female Genital Organs, Malignant Tumors of Independent
Recruiting
- Malignant Neoplasm of Bone and Articular Cartilage
- +9 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Oct 26, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)
Recruiting
- Thyroid Cancer
- Traditional neck dissection approach
- Anterior neck dissection approach
-
Medellin, Antioquia, ColombiaHospital Alma Mater de Antioquia
Nov 20, 2023
Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)
Recruiting
- Differentiated Thyroid Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 9, 2023
Papillary Thyroid Cancer Trial in Baltimore (Radiofrequency Ablation)
Active, not recruiting
- Papillary Thyroid Cancer
- Radiofrequency Ablation
-
Baltimore, MarylandJohns Hopkins Hospital
Dec 5, 2022
Studies on Tumors of the Thyroid
Recruiting
- Hurthle Cell Thyroid Cancer
- +4 more
- 68-Gallium Dotatate
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)
Not yet recruiting
- Thyroid Cancer
- 20 mg Famitinib & 1200 mg Adebrelimab
- (no location specified)
Nov 26, 2023
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)
Not yet recruiting
- Differentiated Thyroid Cancer
- +3 more
- Larotrectinib monotherapy
- 131I therapy
- (no location specified)
Mar 13, 2023
A Detailed Look At What Patients Experience In Medullary Thyroid
Not yet recruiting
- Medullary Thyroid Cancer
-
San Francisco, CaliforniaPower Life Sciences
Oct 6, 2023
Nasolacrimal Duct Obstruction, Thyroid Cancer Trial (Artificial Tears Methylcellulose)
Not yet recruiting
- Nasolacrimal Duct Obstruction
- Thyroid Cancer
- Artificial Tears Methylcellulose
- (no location specified)
Aug 17, 2023
Surgical Management of Advanced Thyroid Cancer
Recruiting
- Thyroid Carcinoma
- +6 more
- Thyroidectomy with or without lymphadenectomy or multivisceral resection
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 31, 2023
Papillary Thyroid Cancer and Central Lymp Node Dissection
Completed
- Papillary Thyroid Cancer
-
Istanbul, TurkeyBasaksehirCamSakuraSehirH
May 15, 2023
Association Between Primary Aldosteronism and Thyroid Cancer
Completed
- Thyroid Cancer, Papillary
- Primary Aldosteronism
- Secreening test for primary aldosteronism and Confirmatory Testing
-
São Paulo, BrazilAna Alice Wolf Maciel
Oct 3, 2023
Quality of Life in Differentiated Thyroid Carcinoma Undergoing
Not yet recruiting
- Thyroid Cancer
- minimally invasive procedure
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hopsital
Sep 13, 2023
Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer
Recruiting
- Thyroid Cancer
- NTRK fusion assessment
-
Roma, ItalyRegina Elena National Cancer Institute
Mar 31, 2023
Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)
Recruiting
- Thyroid Cancer
- +2 more
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 13, 2023
Trends in Anaplastic Thyroid Cancer Patients' Clinical Study
Not yet recruiting
- Anaplastic Thyroid Cancer
- (no location specified)
Apr 6, 2023
Thyroid Cancer Trial in Ann Arbor (Usual Care, CQUPLE)
Recruiting
- Thyroid Cancer
- Usual Care
- CQUPLE
-
Ann Arbor, MichiganThe University of Michigan Cancer Center
Oct 3, 2023
Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)
Recruiting
- Thyroid Cancer
- Recurrence
- prophylactic central neck dissection
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 8, 2023
Thyroglobulin and Galectin-3 for Prognosis and Follow-up in
Recruiting
- Thyroid Cancer
- +2 more
-
Taipei, TaiwanChih-Yuan Wang, M.D
Oct 16, 2022